These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 36841417)
1. Hybrid extracellular vesicles for drug delivery. Ducrot C; Loiseau S; Wong C; Madec E; Volatron J; Piffoux M Cancer Lett; 2023 Apr; 558():216107. PubMed ID: 36841417 [TBL] [Abstract][Full Text] [Related]
2. Generation of Hybrid Extracellular Vesicles by Fusion with Functionalized Liposomes. Piffoux M; Silva AKA; Gazeau F; Tareste D Methods Mol Biol; 2022; 2473():385-396. PubMed ID: 35819777 [TBL] [Abstract][Full Text] [Related]
3. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems. Piffoux M; Silva AKA; Wilhelm C; Gazeau F; Tareste D ACS Nano; 2018 Jul; 12(7):6830-6842. PubMed ID: 29975503 [TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles for drug delivery. Vader P; Mol EA; Pasterkamp G; Schiffelers RM Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656 [TBL] [Abstract][Full Text] [Related]
5. Polyethylene Glycol-Mediated Fusion of Extracellular Vesicles with Cationic Liposomes for the Design of Hybrid Delivery Systems. Mukherjee D; Paul D; Sarker S; Hasan MN; Ghosh R; Prasad SE; Vemula PK; Das R; Adhikary A; Pal SK; Rakshit T ACS Appl Bio Mater; 2021 Dec; 4(12):8259-8266. PubMed ID: 35005950 [TBL] [Abstract][Full Text] [Related]
6. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767 [TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495 [TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives. Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664 [TBL] [Abstract][Full Text] [Related]
9. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source. Meng W; He C; Hao Y; Wang L; Li L; Zhu G Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719 [TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System. Shahjin F; Chand S; Yelamanchili SV J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884 [TBL] [Abstract][Full Text] [Related]
11. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems. Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765 [TBL] [Abstract][Full Text] [Related]
12. Low concentration of polyethylene glycol facilitates separation of extracellular vesicles from bronchoalveolar lavage fluid. Lee H; He X; Ni K; Carnino JM; Jin Y Am J Physiol Lung Cell Mol Physiol; 2021 Apr; 320(4):L522-L529. PubMed ID: 33438468 [TBL] [Abstract][Full Text] [Related]
13. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity. Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896 [TBL] [Abstract][Full Text] [Related]
14. Interest of extracellular vesicles in regards to lipid nanoparticle based systems for intracellular protein delivery. Le Saux S; Aubert-Pouëssel A; Mohamed KE; Martineau P; Guglielmi L; Devoisselle JM; Legrand P; Chopineau J; Morille M Adv Drug Deliv Rev; 2021 Sep; 176():113837. PubMed ID: 34144089 [TBL] [Abstract][Full Text] [Related]
15. Nucleic acid delivery with extracellular vesicles. Schulz-Siegmund M; Aigner A Adv Drug Deliv Rev; 2021 Jun; 173():89-111. PubMed ID: 33746014 [TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles as drug delivery systems: Why and how? Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351 [TBL] [Abstract][Full Text] [Related]
17. A focus on critical aspects of uptake and transport of milk-derived extracellular vesicles across the Caco-2 intestinal barrier model. Roerig J; Schiller L; Kalwa H; Hause G; Vissiennon C; Hacker MC; Wölk C; Schulz-Siegmund M Eur J Pharm Biopharm; 2021 Sep; 166():61-74. PubMed ID: 34077790 [TBL] [Abstract][Full Text] [Related]
18. Engineering and loading therapeutic extracellular vesicles for clinical translation: A data reporting frame for comparability. Piffoux M; Volatron J; Cherukula K; Aubertin K; Wilhelm C; Silva AKA; Gazeau F Adv Drug Deliv Rev; 2021 Nov; 178():113972. PubMed ID: 34509573 [TBL] [Abstract][Full Text] [Related]
19. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles. Evers MJW; van de Wakker SI; de Groot EM; de Jong OG; Gitz-François JJJ; Seinen CS; Sluijter JPG; Schiffelers RM; Vader P Adv Healthc Mater; 2022 Mar; 11(5):e2101202. PubMed ID: 34382360 [TBL] [Abstract][Full Text] [Related]
20. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles. Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]